When did TRAVERE THERAPEUTICS INC (TVTX) report earnings last quarter?
TRAVERE THERAPEUTICS INC (TVTX) last reported earnings on 2/19/2026.
TRAVERE THERAPEUTICS INC (TVTX) Earnings History & Surprises
NASDAQ:TVTX • US89422G1076
Current stock price
40.5 USD
-0.32 (-0.78%)
At close:
40.29 USD
-0.21 (-0.52%)
After Hours:
TVTX Earnings overview
Past quarterly earnings results for TRAVERE THERAPEUTICS INC (TVTX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Apr 30, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.22
- Revenue Estimate
- 139M
Last Reported
Most Recent- Release Date
- Feb 19, 2026
- Period
- Q4 / 2025
- EPS Reported
- $0.03
- EPS Surprise
- 124.93%
- Revenue Surprise
- -10.61%
Beat Rate
Last 8 Quarters 56%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.03 | -0.12 | 124.93% | 104.11% | 129.689M | 145.08M | -10.61% | 73.41% |
| Q3 2025 | 0.28 | -0.21 | 232.09% | 140.00% | 164.859M | 108.66M | 51.72% | 162.11% |
| Q2 2025 | -0.14 | -0.30 | 53.91% | 84.62% | 114.449M | 102.66M | 11.48% | 111.49% |
| Q1 2025 | -0.47 | -0.55 | 14.67% | 73.30% | 81.732M | 77.043M | 6.09% | 97.54% |
| Q4 2024 | -0.73 | -0.57 | -27.29% | 29.13% | 74.787M | 74.802M | -0.02% | 65.98% |
| Q3 2024 | -0.70 | -0.69 | -1.00% | 40.17% | 62.898M | 61.685M | 1.97% | 69.56% |
| Q2 2024 | -0.91 | -0.88 | -3.62% | 19.47% | 54.116M | 51.172M | 5.75% | -9.35% |
| Q1 2024 | -1.76 | -1.01 | -74.13% | -38.58% | 41.374M | 43.704M | -5.33% | -27.41% |
| Q4 2023 | -1.03 | -1.30 | 20.64% | - | 45.059M | 42.089M | 7.06% | -19.35% |
| Q3 2023 | -1.17 | -0.15 | -703.66% | -7.34% | 37.095M | 121.12M | -69.37% | 32.10% |
| Q2 2023 | -1.13 | -1.16 | 2.89% | -7.62% | 59.697M | 54.786M | 8.96% | 1,576.88% |
| Q1 2023 | -1.27 | -1.19 | -6.34% | -5.83% | 56.993M | 51.621M | 10.41% | 17.54% |
| Q4 2022 | -1.03 | -1.10 | 6.02% | -22.62% | 55.87M | 54.075M | 3.32% | -2.41% |
| Q3 2022 | -1.09 | -0.88 | -23.68% | -84.75% | 28.08M | 55.854M | -49.73% | -58.84% |
| Q2 2022 | -1.05 | -0.89 | -17.48% | -64.06% | 3.56M | 50.619M | -92.97% | -93.48% |
| Q1 2022 | -1.20 | -0.87 | -38.18% | -25.00% | 48.49M | 52.957M | -8.44% | 2.28% |
| Q4 2021 | -0.84 | -0.70 | -20.52% | -75.00% | 57.25M | 58.05M | -1.38% | 12.30% |
| Q3 2021 | -0.59 | -0.55 | -7.52% | -34.09% | 68.22M | 62.152M | 9.76% | 33.40% |
| Q2 2021 | -0.64 | -0.70 | 8.18% | -10.34% | 54.62M | 51.337M | 6.39% | 12.78% |
| Q1 2021 | -0.96 | -0.40 | -140.45% | -4,900.00% | 47.41M | 51.089M | -7.20% | -0.75% |
| Q4 2020 | -0.48 | -0.48 | 0.40% | - | 50.98M | 52.694M | -3.25% | - |
| Q3 2020 | -0.44 | -0.53 | 16.35% | - | 51.14M | 48.81M | 4.77% | - |
| Q2 2020 | -0.58 | -0.57 | -2.00% | - | 48.43M | 48.015M | 0.86% | - |
| Q1 2020 | 0.02 | -0.68 | 102.94% | - | 47.77M | 44.296M | 7.84% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
106.40%
Max EPS beat (4)
232.09%
Min EPS beat (4)
14.67%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
14.67%
Max Revenue beat (4)
51.72%
Min Revenue beat (4)
-10.61%
Analysis
In the last 4 quarters, TVTX has consistently beaten EPS estimates in all releases
TVTX has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, TVTX has beaten the EPS estimates by 106.4% on average.
In the last 4 quarters, TVTX has beaten the revenue estimates by 14.7% on average.
Related analysis
TRAVERE THERAPEUTICS INC / TVTX Earnings FAQ
Did TVTX stock beat earnings estimates in the most recent quarter?
TRAVERE THERAPEUTICS INC (TVTX) beat EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often TRAVERE THERAPEUTICS INC beats earnings estimates?
In the last 4 quarters, TRAVERE THERAPEUTICS INC (TVTX) has beaten EPS estimates in 4 out of 4 releases.